These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 336410)

  • 21. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinically important effects of oral antidiabetic drug interactions].
    Drzewoski J; Kopff B
    Pol Merkur Lekarski; 2000 Sep; 9(51):605-7. PubMed ID: 11126985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral hypoglycemic agents and heart.
    Manoria P; Manoria P
    Indian Heart J; 2007; 59(3):266-72. PubMed ID: 19124937
    [No Abstract]   [Full Text] [Related]  

  • 24. Mode of action of oral hypoglycaemic agents. II. Sulphonylureas & biguanides in rats.
    Augusti KT; Kurup PA
    Indian J Biochem; 1969 Mar; 6(1):36-9. PubMed ID: 4332123
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention, by antidiabetic biguanides, of hepatic cholesteatosis induced by cholesterol in the rabbit. Histopathological examination].
    Marquié G; Agid R; Amiel S; Guilhem A
    C R Seances Soc Biol Fil; 1970; 164(3):648-54. PubMed ID: 4250425
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the mechanism of action of phenethylbiguanide (PEBG). II. Effect on spontaneous and glucagon-induced hepatic glycogenolysis in vitro].
    Fratino P; Rodari T; Maggi G
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1881-3. PubMed ID: 5628805
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative effects of Stevia rebaudiana leaves and stevioside on glycaemia and hepatic gluconeogenesis.
    Ferreira EB; de Assis Rocha Neves F; da Costa MA; do Prado WA; de Araújo Funari Ferri L; Bazotte RB
    Planta Med; 2006 Jun; 72(8):691-6. PubMed ID: 16732523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibition of cyclic 3',5'-nucleotide phosphodiesterase by glypentide and other oral antidiabetic agents (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Dec; 30(4):277-81. PubMed ID: 4376253
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis.
    Doi M; Yamaoka I; Nakayama M; Sugahara K; Yoshizawa F
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1683-93. PubMed ID: 17299083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of centpiperalone in combination with biguanide & sulfonylurea.
    Srivastava PP; Murthy PS; Mukherjee SK
    Indian J Exp Biol; 1983 Jul; 21(7):390-2. PubMed ID: 6365752
    [No Abstract]   [Full Text] [Related]  

  • 31. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
    [No Abstract]   [Full Text] [Related]  

  • 32. [Oral antidiabetics (hypoglycemic sulfamides and biguanides)].
    Vigne J
    Brux Med; 1974 Feb; 54(2):91-7. PubMed ID: 4434244
    [No Abstract]   [Full Text] [Related]  

  • 33. When--and how--to use an oral agent.
    Shuman CR
    Med Times; 1980 May; 108(5):77-81, 85-6. PubMed ID: 7374409
    [No Abstract]   [Full Text] [Related]  

  • 34. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z; Wójcikowski C
    Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inotropic effect of tolbutamide and glipentide in isolated guinea pig atria (author's transl)].
    Sánchez-Casals MS; Morell-Mestre J
    Rev Esp Fisiol; 1974 Dec; 30(4):273-6. PubMed ID: 4456482
    [No Abstract]   [Full Text] [Related]  

  • 36. Sulfonylurea effects on target tissues for insulin.
    McCaleb ML; Maloff BL; Nowak SM; Lockwood DH
    Diabetes Care; 1984; 7 Suppl 1():42-6. PubMed ID: 6376028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoglycaemic drugs.
    Sarges R
    Prog Med Chem; 1981; 18():191-223. PubMed ID: 7045983
    [No Abstract]   [Full Text] [Related]  

  • 38. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract]   [Full Text] [Related]  

  • 40. New oral antidiabetic drugs. Synthesis and structure-activity relationships.
    Francia E; Marin A; Verdejo F; Sanchez MS; Morell J
    Boll Chim Farm; 1975 Jul; 114(7):379-92. PubMed ID: 1164447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.